Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep;140(3):654-662.
doi: 10.1016/j.jaci.2017.07.011. Epub 2017 Aug 1.

Vitiligo: Mechanistic insights lead to novel treatments

Michael L Frisoli  1 , John E Harris  2
Affiliations
Review

Vitiligo: Mechanistic insights lead to novel treatments

Michael L Frisoli et al. J Allergy Clin Immunol. 2017 Sep.

Abstract

Vitiligo is an autoimmune disease of the skin characterized by patchy depigmentation. Current treatments are moderately effective at reversing disease by suppressing autoimmune inflammation in the skin and promoting melanocyte regeneration. Recent basic and translational research studies have significantly improved our understanding of disease pathogenesis, which is now leading to emerging treatment strategies based on targeted therapy. Here we discuss important clinical characteristics of vitiligo, current therapies and their limitations, advances in understanding disease pathogenesis, emerging targeted treatments, and strategies to optimize clinical trials to efficiently and effectively test these new treatments.

Keywords: CXCL10; CXCL9; CXCR3; IFN-γ; NLRP1; NLRP3; T cell; Vitiligo; clinical trials; hair; inflammasome; innate immunity; melanocyte; regeneration; regulation; repigmentation; resident memory; stress; treatment.

PubMed Disclaimer